Jolimark Holdings Limited signed a placing agreement with Gransing Securities on 29 June 2026 to issue up to 122.58 million new shares at HK$0.72 each under its existing general mandate.

The placement price represents a 19.10% discount to the 29 June closing price of HK$0.89, a 16.47% discount to the five-day average of HK$0.862 and an 8.51% discount to the ten-day average of HK$0.787. Based on the maximum placement size, the new shares equal 16.66% of current issued capital and will expand the share base to 858.33 million shares, cutting controlling shareholder Kytronics Holdings’ stake from 60.49% to 51.85%.

Gross proceeds are expected to reach approximately HK$88.30 million; after a 2% placing commission and related expenses, net proceeds are estimated at HK$86.40 million (net issue price: HK$0.70). Jolimark plans to deploy the funds as follows: 1. HK$19.00 million (21.99%) for staff salaries and benefits, 2. HK$40.40 million (46.76%) for procurement of raw materials and day-to-day operations, 3. HK$27.00 million (31.25%) for repayment of outstanding bank loans due on or before 30 September 2026.

The shares will be issued under the general mandate granted on 28 May 2026, which authorized up to 122.58 million new shares; the mandate will be fully utilized upon completion. Listing approval from the Hong Kong Stock Exchange must be obtained by 20 July 2026 for the placement to proceed.

As at 31 December 2025, Jolimark reported negative net assets of RMB44 million and had HK$27 million in bank loans maturing in 2026. Management views the placement as a means to bolster capital, reduce liabilities and support ongoing business development.

In the past 12 months, the company completed a separate placement of 122.58 million shares at HK$0.11 per share in May–June 2026, raising HK$13.00 million, of which HK$9.20 million had been utilized by the date of the current announcement.